StockData

Novavax Inc (NVAX) stock

NVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$7.96+0.00 (0.00%)

Close on Nov 18, 2026Market cap $1.31BP/E –Yield –

Novavax price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Novavax's price to book ratio was 36.2× on Oct 31, 2025, against 12.8× a year earlier. Over the last 5 years it ranged from 3.5× to 130.6×, with a median of 8.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Oct 31, 202536.2×−29.0
2022Jul 29, 202265.2×+41.8
2021Dec 31, 202123.4×−42.5
2020Dec 31, 202065.9×+58.8
2017Jan 31, 20177.1×+0.3
2016Dec 30, 20166.9×+0.7
2015Dec 31, 20156.2×+0.8
2014Dec 31, 20145.4×+0.5
2013Dec 31, 20134.9×+0.8
2012Dec 31, 20124.1×+1.4
2011Dec 30, 20112.7×–

More Novavax figures

See a number that looks wrong?